However, some patients do not respond to omalizumab, and the cause of treatment failure has not been fully elucidated. Objective This study aimed to evaluate the characteristics of adult asthma patients who failed to achieve disease control with omalizumab in a real-world setting. Methods We ...
Recent advances in the understanding of the pathology of asthma have prompted the development of other treatment options. Here, we consider the options available for people who require continuous or frequent use of oral corticosteroids and review the safety and efficacy of such treatments.In the UK...
1,2 The risks associated with long-term systemic corticosteroid treatment are well documented, and have led to the search for alternatives. Recent advances in the understanding of the pathology of asthma have prompted the development of other treatment options. Here, we consider the options ...
Frequency not reported: Asthmatic attach, bronchial hypersecretion/hypersecretion in upper respiratory passages, chest congestion, dyspnea, excessive sneezing, hoarseness, mucus obstruction of the nasopharynx, nosebleed, pneumonia, rhinorrhea, shortness of breath, yawning Postmarketing reports: Airway obstruc...
Frequency not reported: Asthma, hiccup, atelectasis, hyperventilation Postmarketing reports: Respiratory arrest[Ref]References 1. (2006) "Product Information. Ionsys (fentanyl)." Ortho McNeil Pharmaceutical 2. Sebel PS, Bovill JG (1983) "Fentanyl and convulsions." Anesth Analg, 62, p. 858-9 3....
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 2005;60(3):309-316. doi:10.1111/j.1398-9995.2004.00772.xPubMedGoogle ScholarCrossref 19. Maurer ...
Frequency not reported: Asthma, hiccup, atelectasis, hyperventilation Postmarketing reports: Respiratory arrest[Ref] References 1. (2006) "Product Information. Ionsys (fentanyl)."Ortho McNeil Pharmaceutical 2. Sebel PS, Bovill JG (1983) "Fentanyl and convulsions."Anesth Analg, 62, p. 858-9 ...
39. Settipane RA, Stevenson DD (1989) "Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma."J Allergy Clin Immunol, 84, p. 26-33 40. Van Diem L, Grilliat JP (1990) "Anaphylactic shock induced by paracetamol."Eur J Clin Pharmacol, 38, p. 389-90 ...
Uncommon(0.1% to 1%): Dyspnea (including asthmatic conditions), wheezing, bronchospasm, asthma Postmarketing reports: Allergic pneumonitis, laryngeal edema[Ref] References 1. (2001) "Product Information. Avelox (moxifloxacin)."Bayer 2. Mandell LA, Ball P, Tillotson G (2001) "Antimicrobial safety...
39. Settipane RA, Stevenson DD (1989) "Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma." J Allergy Clin Immunol, 84, p. 26-33 40. Van Diem L, Grilliat JP (1990) "Anaphylactic shock induced by paracetamol." Eur J Clin Pharmacol, 38, p. 389-90 41. Leun...